ARTICLES ON VALVULOPATHIES
Evolut Low-Risk Study at Three Years: Clinical Benefit or Statistical Fallacy
A review of the three-year outcomes of the Evolut Low-Risk study and comparison with the published follow-up at one and two years.
Percutaneous versus Surgical Treatment of Functional Mitral Regurgitation: Lessons Learned
A bicentric retrospective study adjusted by propensity score analysis examining 2-year outcomes of percutaneous edge-to-edge therapy compared to surgical intervention for functional mitral regurgitation.
Isolated Tricuspid Surgery: Analysis of The Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database
The American Society of Thoracic Surgeons (STS) registry analyzed 6,507 patients who underwent isolated tricuspid valve surgery.
Mid-term follow-up meta-analysis of the sutureless Livanova® Perceval® aortic valve prosthesis: adaptation to real-world scenarios
This systematic review and meta-analysis is the first study to independently evaluate the mid-term outcomes (5 years) of isolated aortic valve replacement using the Perceval sutureless prosthesis.
Twenty Years of Aortic Valve Reimplantation with Valsalva Graft: Does Preserving the Sinuses of Valsalva Make a Difference?
A retrospective analysis of aortic valve reimplantation outcomes over the last 20 years, using the “Valsalva graft” at the center that introduced its clinical application.
Minimally Invasive Approach in Aortic Valve Replacement vs. TAVI: From Classic to Derby
Patient-level meta-analysis comparing survival outcomes of TAVI vs. aortic valve replacement across different approaches: sternotomy and, innovatively, minimally invasive approach.
Results of the COAPT Study at 5 Years: Sustained Benefit of the MitraClip When Surgery Is Not Feasible?
The COAPT study’s 5-year outcomes assess clinical parameters and mortality in patients with severe secondary mitral regurgitation (MR) after MitraClip implantation.
On-X mitral: Is Reduced Oral Anticoagulation Feasible?
This study is a randomized, multicenter, prospective, open clinical trial comparing clinical outcomes 3 months after implanting an On-X mechanical mitral prosthesis in patients with standard anticoagulation ranges versus a lower target.
Percutaneous Tricuspid Repair: The Definitive Treatment for Moderate- or High-Risk Surgical Patients?
This is a multicenter, randomized clinical trial evaluating outcomes of transcatheter edge-to-edge tricuspid valve repair compared to optimized medical management in 350 patients with severe tricuspid regurgitation.
Transcatheter aortic valve implantation versus surgical aortic valve replacement in aortic insufficiency: is it justified?
Analysis of post-procedure outcomes and mid-term follow-up of TAVI vs. SVA in a U.S. healthcare insurance database for patients with pure aortic insufficiency.